{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:05:04Z","timestamp":1774375504646,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA198776"],"award-info":[{"award-number":["R21CA198776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","award":["UL1TR00043"],"award-info":[{"award-number":["UL1TR00043"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001502","name":"Blue Cross Blue Shield of Michigan Foundation","doi-asserted-by":"publisher","award":["2193.11"],"award-info":[{"award-number":["2193.11"]}],"id":[{"id":"10.13039\/100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001634","name":"Gateway for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bbmt.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T06:53:34Z","timestamp":1537426414000},"page":"343-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Flora","family":"Hoodin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"LaLonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josh","family":"Errickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Votruba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Kentor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Gatza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-3834","authenticated-orcid":false,"given":"Sung Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.09.015_bib0001","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","article-title":"Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT","volume":"53","author":"Buchbinder","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0002","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbmt.2017.09.004","volume":"24","author":"Kelly","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0003","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/bmt.2013.61","article-title":"A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation","volume":"48","author":"Phillips","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2017.74.2270","article-title":"Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study","volume":"36","author":"Sharafeldin","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0006","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2013.01.041","article-title":"Epigenetic mechanisms in mood disorders: targeting neuroplasticity","volume":"264","author":"Fass","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13148-017-0365-z","article-title":"Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders","volume":"9","author":"Delgado-Morales","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0008","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2119\/molmed.2011.00007","article-title":"HDAC inhibition and graft versus host disease","volume":"17","author":"Choi","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-011112-140216","article-title":"The potential of HDAC inhibitors as cognitive enhancers","volume":"53","author":"Graff","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/BST20130233","article-title":"HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand","volume":"42","author":"Whittle","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0011","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00213-011-2353-x","article-title":"Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial","volume":"218","author":"Kuriyama","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0012","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood-2017-06-790469","article-title":"Vorinostat plus tacrolimus\/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT","volume":"130","author":"Choi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cct.2006.10.010","article-title":"Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated phase I study","volume":"28","author":"Collie","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0014","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bandc.2005.05.001","article-title":"The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature","volume":"59","author":"Falleti","year":"2005","journal-title":"Brain Cogn"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0891988712447894","article-title":"Validity of a brief computerized cognitive screening test in dementia","volume":"25","author":"Hammers","year":"2012","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0016","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000080229","article-title":"Subtle memory decline over 12 months in mild cognitive impairment","volume":"18","author":"Maruff","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0017","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0019","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bmt.1701115","article-title":"Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year","volume":"21","author":"McQuellon","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0020","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0021","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0022","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.genhosppsych.2015.11.005","article-title":"Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis","volume":"39","author":"Plummer","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0024","series-title":"Stata Statistical Software: Release 15","year":"2017"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0025","series-title":"IBM SPSS Statistics for Windows","year":"2016"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0026","series-title":"Linear mixed models: A practical guide using statistical software","author":"West","year":"2014"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0027","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/10635150490522304","article-title":"Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests","volume":"53","author":"Posada","year":"2004","journal-title":"Syst Biol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0028","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1002\/cncr.26645","article-title":"Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation","volume":"118","author":"Jim","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0029","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/pon.3159","article-title":"Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study","volume":"22","author":"Scherwath","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1705663","article-title":"Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies","volume":"39","author":"Schulz-Kindermann","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl)","key":"10.1016\/j.bbmt.2018.09.015_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1188\/14.CJON.S3.17-25","article-title":"Evidence-based interventions for cancer- and treatment-related cognitive impairment","volume":"18","author":"Von Ah","year":"2014","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0032","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/pon.4058","article-title":"Web-based cognitive training for breast cancer survivors with cognitive complaints-a randomized controlled trial","volume":"25","author":"Damholdt","year":"2016","journal-title":"Psychooncology"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-009-0006-2","article-title":"Neurocognitive training in patients with high-grade glioma: a pilot study","volume":"97","author":"Hassler","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0034","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1470-2045(13)70512-6","article-title":"Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1\/2 trial","volume":"15","author":"Choi","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0035","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bbmt.2017.08.006","article-title":"The role of age in neurocognitive functioning among adult allogeneic hematopoietic cell transplant recipients","volume":"23","author":"Hoogland","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0036","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/cncr.30546","article-title":"Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation","volume":"123","author":"El-Jawahri","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0037","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/bmt.2016.191","article-title":"Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Ehrlich","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.09.015_bib0038","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cncr.29717","article-title":"Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)","volume":"122","author":"Wood","year":"2016","journal-title":"Cancer"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911830572X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911830572X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:04:04Z","timestamp":1761059044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911830572X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S108387911830572X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.09.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}